BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, January 25, 2026
See today's BioWorld Asia
Home
» Hainan Haiyao branches out, sets up $20M fund to buy into innovation
To read the full story,
subscribe
or
sign in
.
Hainan Haiyao branches out, sets up $20M fund to buy into innovation
April 2, 2014
By
Shannon Ellis
SHANGHAI – Hainan Haiyao Co. Ltd., of Haikou, China, revealed in a regulatory filing that is has some cash to spend and is seeking to buy its way into some new opportunities, with biotechs at the top of its list.
BioWorld Asia